172 related articles for article (PubMed ID: 25896926)
1. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
[TBL] [Abstract][Full Text] [Related]
2. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
[TBL] [Abstract][Full Text] [Related]
3. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
4. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
[TBL] [Abstract][Full Text] [Related]
6. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
7. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
[TBL] [Abstract][Full Text] [Related]
8. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
9. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
10. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
11. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.
Buist DS; Walker R; Bowles EJ; Carney PA; Taplin SH; Onega T; Kerlikowske K; Clinton W; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):720-7. PubMed ID: 22301831
[TBL] [Abstract][Full Text] [Related]
12. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
13. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
15. Benefit-to-harm ratio of the Danish breast cancer screening programme.
Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
[TBL] [Abstract][Full Text] [Related]
16. Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data.
Weedon-Fekjær H; Li X; Lee S
J Med Screen; 2021 Sep; 28(3):302-310. PubMed ID: 32854582
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.
Kim G; Mikhael PG; Oseni TO; Bahl M
Eur Radiol; 2020 Nov; 30(11):6089-6098. PubMed ID: 32591884
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.
Jacklyn G; Morrell S; McGeechan K; Houssami N; Irwig L; Pathmanathan N; Barratt A
Breast; 2018 Feb; 37():170-178. PubMed ID: 28882419
[TBL] [Abstract][Full Text] [Related]
19. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
20. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]